Fig. 2From: Higher sclerostin is associated with pulmonary hypertension in pre-dialysis end-stage kidney disease patients: a cross-sectional prospective observational cohort studySurvival graph according to sclerostin using Kaplan–Meier method. Sclerostin did not show a significant effect as a risk factor for mortality (p = 0.28)Back to article page